{
  "@context": {
    "bioagents": "https://bio.agents/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://doi.org/10.1038/S41598-020-76161-8",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://bio.agents/firm-avp",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalAgent/0.6-DRAFT",
      "sc:additionalType": "Web application",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_0154"
        },
        {
          "@id": "edam:topic_0082"
        },
        {
          "@id": "edam:topic_3474"
        }
      ],
      "sc:citation": [
        "pubmed:33159146",
        {
          "@id": "https://doi.org/10.1038/S41598-020-76161-8"
        },
        "pmcid:PMC7648056"
      ],
      "sc:description": "FIRM-AVP is a agent for antiviral peptide prediction. It is used for better understanding and prediction of antiviral peptides through primary and secondary structure feature importance.",
      "sc:featureList": [
        {
          "@id": "edam:operation_0253"
        },
        {
          "@id": "edam:operation_0267"
        },
        {
          "@id": "edam:operation_3936"
        }
      ],
      "sc:name": "FIRM-AVP",
      "sc:url": "https://msc-viz.emsl.pnnl.gov/AVPR"
    }
  ]
}